Aim: Identifying local determinants of the Healthcare-associated infections(HCAI) burden and improving reporting and surveillance systems is the first step to find active action programs against HCAI. The aim of this study was to evaluate and describe the results of surveillance of HCAIs in a Leve lIII intensive care unit( ICU ) between January 2011 and December 2016. Material and Method: Children aged between 28 days and 18 years with HCAI in the ICU were included in the study. The definition of HCAI was based on the 2008 CDC diagnostic criteria. Results: During 6 years7211 patients were admitted in the ICU. Infection rate was 12.6 infections per 1000 resident days. Between2011 and 2016, %60.3 reduction in the central line-associated bloodstream infections (CLABSI), 61.1% reduction in ventilatory-associated pneumonia (VAP) was observed.Prior to implementation of VAP bundle in 2013, the incidence of VAP was 10.7/1000 ventilator days. After the implementation of VAP bundle, 71.7% reduction was reported in VAP between 2013 and 2016. Of 342 infections, the most common infections were pneumonia (n=182, 53.2%), bloodstream infections(n=86, 25.2%) and urinary tract infections (n=62, 18.1%). A total of 435 infectious agents were isolated. Acinetobacter baumanni was the most commonly reported pathogen(25.05%) followed secondly by Klebsiella pneumoniae (17.01% ). Discussion: Surveillance data are useful to identify interventions needed and to assess the interventions to improve infection rates.Education of the health care providers, multidisciplinary team approach and strict criteria to define appropriate indications for the use of indwelling catheters, devices and strict adherence to bundles are vital to decrease the HCAI rates.
Introduction
Despite progress in public health and hospital care, infections continue to develop in hospitalized patients. HCAI rate in patients in a facility is an indicator of quality and safety of care.
The development of a surveillance process to monitor this rate is an essential first step to identify local problems and priorities and evaluate the effectiveness of infection control activity.
Surveillance, by itself, is an effective process to decrease the frequency of hospital-acquired infections [1] .ICU patients are prone to infection due to prolonged hospital stay, underlying severe diseases, presence of multiple invasive devices.In addition, the use of broad-spectrum antimicrobial agents has led to emergence of multidrug-resistant organisms in ICU [2] .In developing countries, there is a lack of surveillance at both national and local level.In our country, national active surveillance pro- Central line-associated bloodstream infections(CLABSI) and VAP prevention bundles involveevidence-based clinical practice guidelines in an attempt to reduce the incidence of these infections among patients at risk. These bundleshave been available for many years although VAP bundle practice was initiated in 2013 in our institution [3] .The aim of our study was to describe the burden of HCAI infections in our pediatric ICU patients by the comparison of institutional survey reports withthe national surveillance reports.The impact of bundle practice on reducing the incidence of VAP infections, CLABSI, catheter-associated urinary tract infections(CAUTI) was evaluated.
Material and Method

Setting and Design:
This study was conducted in a tertiary hospital in a Level III The roles of ICNs were to monitor, identify, prevent and control the occurrences of infectious diseases. ICNs evaluated clinical settings to check that infection control guidelines and policies were followed. They were also involved in lab tests to review findings and identify positive culture results.All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Measurements
Frequency measures were calculated as the percent of infection and as incidence densities, i.e. infection rates per 1000 days of hospital stay or 1000 days of directly related invasive device. Device utility ratio was formulated as follows: number of device-days/number of patient-days. To Calculate the deviceassociated infection rate (per 1000 device-days) the following formula was used: device-associated infection rate/number of device-associated infections for an infection site x 1000 number of device-days.
Care Bundles
Our VAP bundle includes the following: adherence to hand hygiene,assessment of readiness to extubate, oral care with chlorhexidine, head-of-bed elevation of 35 degrees to 45 degrees if there are no contraindications, strictly use of aseptic technique during airway-related procedures.VAP bundle was initiated in 2013. Our CLABSI bundle includes the following: hand hygiene before handling,chlorhexidine for site infection site dressing changes, daily catheter care by aseptic technique, search for the local sign of infection, search for requirement of the central line.
CLABSI bundle was initiated in 2013
Our CAUTI bundles include the following: hand hygiene, daily catheter care by aseptic technique, closed drainage system, drainage bag above flor, below the bladder level, assessment of requirement for catheter. CAUTI bundle was initiated in 2015. ICU surveillance reports were compared to the reports by the National Healthcare-associated infection surveillance reports.
Statistical Analysis:
Statistical analysis was performed using SPSS 19 software (IBM Corporation, New York, United States).Continuous outcomes are presented in median, percentile, whereas discrete variables are presented in terms of frequency distribution. Results were stratified by surveillance year.We used the Kruskal Wallis H testto compare CLABSI, CAUTI VAP incidence rates. ICU surveillance reports were compared to the reports by the National Healthcare-associated infection surveillance reports.
Results
Between 2011 and 2016, 7211 patients were followed in the ICU. Surveillance data were collected for 342 patients (127 females (37.1%)and 215 males (62.9%)) hospitalized in the ICU for a total of 27115 ICU days. The total incidence density of HCAIs during the study period was 12.61 per 1000 patient days and the total infection rate was 4.74%. VAP (48.8%, 6.71/1000 device days) was the most commonly encountered type of infection. CLABSI (37.2%, 3.17/1000 catheter days) was the second commonly encountered type of infection followed by CAUTI (14%, 2.28/1000 catheter days).A decrease in VAP incidence rate ranging from 7.49 to 3.09/1000 ventilator days was observed during the period 2011-2016. A decrease in CLABSI incidence rate ranging from 6.03 to 3.17/1000 catheter days and a decrease in CAUTI incidence rate ranging from 3.12 to 1.52/1000 catheter days was observed during 2011-2016 period. Figure 1 shows the decrease of device-associated infection incidence rates during 2011-2016.
Device utilization rates for mechanical ventilation, central catheters, and urinary catheters were high and compared to national healthcare-associated infections surveillance data it was not different from the other ICUs of the university hospitals.
Device-associated infection incidence rates and device utilization rates during the study period were demonstrated on Tables   1-3 .
Before bundle care on VAP in 2012 VAP infection incidence rate was 9.79/1000 device days. After implementation of VAP bundle in 2013 infection incidence decreased to 3.06/1000 device days in 2016.Effect of bundle care intervention on VAP, CLABSI, and CAUTI (P < 0.001) was statistically significant. VAP, CLABSI and CAUTI incidence rates between 2011 and 2016 were demonstrated on Table 4 .
Microorganism in CLABSIs
The most prevalent source of CLABSIs were Acinetobacter Baumannii and Klebsiella Pneumonia (n =21, 20.4%), it was followed by Candida parapisilosis (n=12, 11.7%), Candida albicans(n=7, 6.8%), Coagulase-negative staphylococci (n=6, 5.9%) and Pseudomanas aeroginosa (n=6, 5.9%). In 5 ( 5.8%)cases Escherichia coli and in 2 (1.9%) casestaphylococcus Aureus were detected. 
Microorganism in CAUTIs
Candida albicans (15.4%) was the most prevalent in CAUTI infections. Candida nonalbicans was the second most prevalent infection (14.7%). Klebsiella pneumonia was the third most common CAUTI infection (10.3%).The other sources of CAUTI were: Pseudomanas Aeroginosa in 12(8.8%) cases, Acinetobacter Baumanni in 9 cases (6.6%) ( Table 4 ).
Discussion
A 2011 prevalence survey conducted by CDC and the Emerging Infections Program (EIP) in the USA showed that 1 in 25 hospital patients had ≥1 HCAI [4] . In a multicenter cohort study, VAP incidence declined from 5.5 to 0 cases per 1000 ventilator days across 110 ICUs with institution of a bundle that included semirecumbent positioning, minimization of sedation, daily assessments for extubation, stress ulcer prophylaxis, and deep vein thrombosis prophylaxis. In another cohort study, VAP incidence declined from 23 to 13 episodes per 1000 ventilator days with the institution of a bundle [3, 8] . Our study demonstrates the success of a VAP bundle in reducing the incidence of VAP. Compliance was achieved by incorporating the bundle into daily multidisciplinary rounds and through regular audit and feedback. Central venous catheters (CVCs) are increasingly used in the inpatient and outpatient setting to provide long-term venous Urinary tract infection is one of the most common hospitalacquired infections; 70%-80% of these infections are attributable to an indwelling urethral catheter [16] . The burden of CAUTI in pediatric patients is not well defined.A CAUTI prevention program including education, implementation of common CAUTI prevention practices, outcomes and process measures, and feedback of CAUTI outcomes and process measures was implemented in pediatric ICUs in 6 developing countries, and a decrease in CAUTI rates from 5.9 to 2.6 per 1,000 catheterdays (relative risk, 0.43 [95% CI, 0.21-1.0]) was reported [17] . Altough according to CDC reports,no change in overall CAUTI between 2009 and 2014 was reported in USA [CDC,2014] .
In the present study,gram-negative organisms were more commonly isolated than gram-positive organisms. Acinetobacter was involved in 32.8 % of all infections, Klebsiella Pneumonia was involved in 17.6% of all infections. Similar to the our results, in a recent report the majority of isolated pathogens were Gram-negative bacteria, and the proportion of Gram-positive bacteria was < 20% [18] . This change appears to be related to the increasing antimicrobial resistance among Gram-negative bacteria and may thus be contributing to Gram-negative bacteria as dominant pathogens [19] .
Conclusion
In summary, our survey results indicate that pneumonia and blood stream infections were the most common infection types of HCAI and Acinetobacter Baumanii was the most common pathogen. This report describes significant reductions reported at the ICU level between 2013 and 2016 with the imnplementation of care bundles for all infection types when compared to the baseline data.HCAIs are major but preventable threat to patient safety and are strongly associated with the use of invasive devices. Steps can be taken to control and prevent the HCAIs in a variety of settings. Such measures often include educational programs, technical measures, surveillance, and feedback.
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